We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
In Silico Identification of Lead Compounds for Pseudomonas Aeruginosa PqsA Enzyme: Computational Study to Block Biofilm Formation.
- Authors
Shahab, Muhammad; Danial, Muhammad; Khan, Taimur; Liang, Chaoqun; Duan, Xiuyuan; Wang, Daixi; Gao, Hanzi; Zheng, Guojun
- Abstract
Pseudomonas aeruginosa is an opportunistic Gram-negative bacterium implicated in acute and chronic nosocomial infections and a leading cause of patient mortality. Pseudomonas aeruginosa infections are frequently associated with the development of biofilms, which give the bacteria additional drug resistance and increase their virulence. The goal of this study was to find strong compounds that block the Anthranilate-CoA ligase enzyme made by the pqsA gene. This would stop the P. aeruginosa quorum signaling system. This enzyme plays a crucial role in the pathogenicity of P. aeruginosa by producing autoinducers for cell-to-cell communication that lead to the production of biofilms. Pharmacophore-based virtual screening was carried out utilizing a library of commercially accessible enzyme inhibitors. The most promising hits obtained during virtual screening were put through molecular docking with the help of MOE. The virtual screening yielded 7/160 and 10/249 hits (ZINC and Chembridge). Finally, 2/7 ZINC hits and 2/10 ChemBridge hits were selected as potent lead compounds employing diverse scaffolds due to their high pqsA enzyme binding affinity. The results of the pharmacophore-based virtual screening were subsequently verified using a molecular dynamic simulation-based study (MDS). Using MDS and post-MDS, the stability of the complexes was evaluated. The most promising lead compounds exhibited a high binding affinity towards protein-binding pocket and interacted with the catalytic dyad. At least one of the scaffolds selected will possibly prove useful for future research. However, further scientific confirmation in the form of preclinical and clinical research is required before implementation.
- Subjects
PSEUDOMONAS aeruginosa; PSEUDOMONAS aeruginosa infections; DRUG resistance in bacteria; NOSOCOMIAL infections; ENZYMES; RHAMNOLIPIDS
- Publication
Biomedicines, 2023, Vol 11, Issue 3, p961
- ISSN
2227-9059
- Publication type
Article
- DOI
10.3390/biomedicines11030961